Skip to main content

Table 2 Serostatus of vaccinated and unvaccinated girls

From: Optimization of a protocol for the evaluation of antibody responses to human papillomavirus (HPV) vaccination in low-resource settings

 

Vaccine

n = 49

n (%)

Control

n = 40

n (%)

P-value

HPV-16

  

 < 0.001

 Positive

31 (63.3)

5 (12.5)

 

 Borderline

14 (28.6)

2 (5.0)

 

HPV-18

  

0.042

 Positive

17 (34.7)

8 (20.0)

 

 Borderline

5 (10.2)

2 (5.0)